Anixa Biosciences Inc Revenue From Contract With Customer Excluding Assessed Tax

Quick Answer

Anixa Biosciences Inc reported Revenue From Contract With Customer Excluding Assessed Tax of $210.0 thousand for the year ending 2023.

  • Anixa Biosciences Inc showed a decrease of -59.0% in Revenue From Contract With Customer Excluding Assessed Tax from 2021 to 2023.
  • This data is from Anixa Biosciences Inc's annual report (Form 10-K), filed with the SEC on January 10, 2025.
  • XBRL data for this metric is available from 2019 to 2023 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 3 years of available data (2019 to 2023), Anixa Biosciences Inc's Revenue From Contract With Customer Excluding Assessed Tax has declined by 16.0%.
  • Historical annual values: Fiscal year 2023: $210.0 thousand | Fiscal year 2021: $512.0 thousand | Fiscal year 2019: $250.0 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: